In recent decades, the zebrafish has become one of the most valuable model organisms in scientific research. For a variety of ...

Neutrophil extracellular traps (NETs) are intricate structures released by neutrophils to ensnare pathogens. While crucial ...

Filed Phase 3 Amendment Incorporates PFS as Interim Primary Endpoint Expected to Shorten Trial Duration and Reduce Costs Conference Call and Webcast Today at 8:00 am Eastern Time PRINCETON, N.J.

Filed Phase 3 Amendment Incorporates PFS as Interim Primary Endpoint Expected to Shorten Trial Duration and Reduce CostsConference Call and ...

Debuting at SXSW, the comedy follows a young woman who, in the wake of a devastating break-up, becomes increasingly fixated on her ex-boyfriend's ex-girlfriend. By Angie Han Television Critic There ...

Geroscience shifts the medical focus from treating individual diseases to targeting the fundamental biological drivers of aging. Cellular senescence involves aging cells that cease division but ...

Disruptions of wound healing phases of the skin lead to chronic wound formation, excessive wound healing, substantial consumption of resources and long-term medical management (1). Extensive skin ...

Every time a cell divides, it must copy its entire genome so that each daughter cell inherits a complete set of DNA. During that process, enzymes known as polymerases race along the DNA to copy its ...

Burrowing shrimp are a well-documented native pest species in Willapa Bay that have been a nuisance to bottom-culture shellfish farmers for over a century. Methods for controlling shrimp populations ...

Here’s my thesis: biotech remains one of the most exciting and promising industries in the world, driven by the inescapable reality that nothing matters more than our health. Despite the fact that in ...

Arthur Herman’s op-ed, “America Is the Sole Superpower Again,” (Jan. 15) asserts that China is “sliding into a distant second place” in the battle for economic, military and technological supremacy.

Immunology biotech Agomab Therapeutics and eye-focused SpyGlass Pharma have both unveiled their intentions to go public in the latest sign the IPO window is reopening in 2026. Neither company has set ...